Calcitonin gene–related peptide in migraine: from pathophysiology to treatment
Introduction: It has been observed in recent years that levels of such molecules as calcitonin gene–related peptide (CGRP) and, to a lesser extent, the pituitary adenylate cyclase–activating peptide are elevated during migraine attacks and in chronic migraine, both in the cerebrospinal fluid and in...
Main Authors: | S. Santos-Lasaosa, R. Belvís, M.L. Cuadrado, S. Díaz-Insa, A. Gago-Veiga, A.L. Guerrero-Peral, M. Huerta, P. Irimia, J.M. Láinez, G. Latorre, R. Leira, J. Pascual, J. Porta-Etessam, M. Sánchez del Río, J. Viguera, P. Pozo-Rosich |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier España
2022-06-01
|
Series: | Neurología (English Edition) |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2173580821000675 |
Similar Items
-
Safety of anti-CGRP monoclonal antibodies in patients with migraine during the COVID-19 pandemic: Present and future implications
by: E. Caronna, et al.
Published: (2021-10-01) -
Safety of anti-CGRP monoclonal antibodies in patients with migraine during the COVID-19 pandemic: Present and future implications
by: E. Caronna, et al.
Published: (2021-10-01) -
Switching of monoclonal antibodies against the calcitonin gene-related peptide or its receptor in migraine. Results from a Spanish Cohort
by: J. Arzalluz-Luque, et al.
Published: (2024-10-01) -
Experience with erenumab: Data from real clinical practice
by: E. Morales Bacas, et al.
Published: (2022-07-01) -
Consenso sobre anticuerpos monoclonales en migraña del Grupo de Estudio de Cefaleas de la Asociación Madrileña de Neurología
by: Germán Latorre González, et al.
Published: (2023-01-01)